• [stock-market-ticker symbols="AAPL;MSFT;GOOG;HPQ;^SPX;^DJI;LSE:BAG" stockExchange="NYSENasdaq" width"100%" palette="financial-light"]

    GAVI, WHO, Related Organizations Funding Local Vaccine Development To Fool Developing Nations Vaccines Forced On Them Are Their Own

    March 31, 2024
    No Comments

    No, peons, this is not a project out of Geneva, London or New York. Trust us. You will get the best BioNTech mRNA vaccines from a factory shipped to Rwanda last year from Germany, run by German staff

    Please Follow us on Gab, Minds, Telegram, Rumble, GETTR, Truth Social, Twitter 

    Guest post Dr. Meryl Nass

    GAVI plans to spend a billion dollars on local vaccine production here. But some say local production is a bad idea. I do too, because it is simply a scam; you cannot set up a vaccine factory without a massive infrastructure to support it and well-trained and well-honed staff to manage it and troubleshoot the problems as they arise.

    India’s Serum Institute is the world’s largest vaccine manufacturing facility and they are pushing back, though for commerical reasons, explaining that local production will actually cost more.



    One lesson the Serum Institute’s leadership has drawn from the Indian company’s history is a commitment to economies of scale — and that’s led them to resist the growing demand for local vaccine production.

    Scaling a giant

    Anyone in the vaccine game knows of the Serum Institute. Already the world’s largest vaccine manufacturer — and a critical conduit of jabs to lower-income countries — the Indian biotechnology company is looking to make itself globally indispensable with a new malaria vaccine and a critical role in a new venture to respond to future outbreaks in less than 100 days.

    But while Serum is expanding rapidly, it doesn’t believe local communities should be trying to follow in its footsteps.

    One of the lessons that Serum’s CEO Adar Poonawalla has drawn from his company’s history is a commitment to economies of scale — and that has led him to caution against the burgeoning demand for local production, which grew out of the blatant vaccine hoarding seen during the COVID-19 pandemic.

    Whereas most manufacturers produce vaccines in the tens of millions, Serum has the capacity to manufacture hundreds of millions, Poonawalla tells Devex contributor Andrew Green. “That brings about economies of scale,” he says, “and you can bring down the prices.”

    “If you want these countries to get a product at the lowest possible price, you have to make it in one location or maybe two locations that are very large-scale to be able to do that,” he advises. The formula seems to be working for Serum: The institution estimates that roughly two-thirds of the world’s children receive at least one vaccine manufactured there.

    ‘NO AD’ subscription for CDM!  Sign up here and support real investigative journalism and help save the republic!  



    CDM Staff

    The mission at Creative Destruction Media is to be the catalyst for the "process of industrial mutation that incessantly revolutionizes the economic structure from within, incessantly destroying the old one, incessantly creating a new one."
  • Subscribe
    Notify of

    Inline Feedbacks
    View all comments


  • Subscribe to our evening newsletter to stay informed during these challenging times!!